Scinopharm Taiwan Ltd. operates as a specialized pharmaceutical company that focuses on the research, development, and manufacture of active pharmaceutical ingredients (APIs). Known for its strong emp... Scinopharm Taiwan Ltd. operates as a specialized pharmaceutical company that focuses on the research, development, and manufacture of active pharmaceutical ingredients (APIs). Known for its strong emphasis on technological innovation and quality control, Scinopharm serves as a crucial entity in the global pharmaceutical supply chain. The company's product portfolio spans a variety of therapeutic categories, including oncology, central nervous system disorders, and cardiovascular diseases. Scinopharm's facilities adhere to international regulatory standards, ensuring the production of APIs that meet stringent quality criteria for both generic and branded pharmaceuticals. With strategic locations in Taiwan and China, the company efficiently caters to the demands of pharmaceutical manufacturers worldwide. Scinopharm's commitment to advanced manufacturing processes and collaborative development projects positions it as a leader in the pharmaceutical manufacturing industry, contributing significantly to enhancing drug availability and accessibility across global healthcare markets.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Energy Management data not yet covered for ScinoPharm Taiwan

We have not yet reviewed ScinoPharm Taiwan's disclosures for Energy Management data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review ScinoPharm Taiwan's data?

Start your 30-day free trial to request a data review for ScinoPharm Taiwan.

Start Free Trial

Legal Center Contact Us